These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3530545)

  • 1. Use of artificial devices in intensive insulin therapy of diabetes mellitus.
    Rizza RA
    Clin Chem; 1986 Oct; 32(10 Suppl):B97-102. PubMed ID: 3530545
    [No Abstract]   [Full Text] [Related]  

  • 2. Closed-loop insulin delivery: is the Holy Grail near?
    Renard E
    Lancet; 2010 Feb; 375(9716):702-3. PubMed ID: 20138356
    [No Abstract]   [Full Text] [Related]  

  • 3. Artificial endocrine pancreas and optimal blood glucose regulation in diabetic patients--from bedside-type to wearable-type.
    Shichiri M; Kishikawa H; Sakakida M; Kajiwara K; Hashiguchi Y; Nishida K; Uemura T; Konno Y; Ichinose K
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S251-9. PubMed ID: 7859615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pump therapy guidelines for China (July 2010).
    Mu Y; Yin S;
    J Diabetes; 2012 Jun; 4(2):127-39. PubMed ID: 22107806
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes Technology and Exercise.
    Riddell MC; Pooni R; Fontana FY; Scott SN
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):109-125. PubMed ID: 31980112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intensive insulin therapy: results after ten years].
    Laube H
    Pharm Unserer Zeit; 2001 Jan; 30(1):40-5. PubMed ID: 11233182
    [No Abstract]   [Full Text] [Related]  

  • 7. Closed-loop insulin delivery - what lies between where we are and where we are going?
    Steil GM; Rebrin K
    Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion--an historical perspective.
    Skyler JS
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S5-9. PubMed ID: 20515307
    [No Abstract]   [Full Text] [Related]  

  • 9. [The dawn phenomenon in diabetes mellitus].
    Shikano M; Sobajima H
    Nihon Rinsho; 1997 Nov; 55 Suppl():687-94. PubMed ID: 9434549
    [No Abstract]   [Full Text] [Related]  

  • 10. Open-loop device Microjet MC 2 improves unstable diabetes, lowers the daily insulin requirement and reduces the excursions of plasma free insulin levels: comparison with a traditional intensive treatment.
    Micossi P; Raggi U; Dosio F; Scavini M; Bertin A; Pozza G
    J Endocrinol Invest; 1983 Jun; 6(3):189-94. PubMed ID: 6352793
    [No Abstract]   [Full Text] [Related]  

  • 11. Artificial devices for continuous insulin administration: an outlook.
    Micossi P; Spotti D; Pozza G
    Int J Artif Organs; 1984 Jan; 7(1):1-6. PubMed ID: 6365796
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current technics in the improvement of insulin treatment].
    Spinas GA; Berger W
    Ther Umsch; 1989 Oct; 46(10):715-21. PubMed ID: 2683184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aids for insulin users.
    Berg EG
    Diabetes Forecast; 2014 Jan; 67(1):70-5. PubMed ID: 25868300
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances toward the implantable artificial pancreas for treatment of diabetes.
    Jaremko J; Rorstad O
    Diabetes Care; 1998 Mar; 21(3):444-50. PubMed ID: 9540030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Flexibility and effectiveness of diabetes therapy].
    Krankenpfl J; 2005; 43(1-3):62. PubMed ID: 15912849
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormonal and metabolic profiles in insulin-dependent diabetics under subcutaneous conventional and artificial endocrine pancreas (glucose continuous insulin infusion system Biostator) treatment.
    Calabrese G; Bueti A; Santeusanio F; Giombolini A; Zega G; Bellomo G; Antonella MA; Angeletti G; Massi-Benedetti M; Brunetti P
    J Endocrinol Invest; 1983 Feb; 6(1):1-8. PubMed ID: 6341441
    [No Abstract]   [Full Text] [Related]  

  • 17. What's new: insulin pump vs conventional therapy.
    Feinstein DM
    Tex Med; 1983 Feb; 79(2):40-2. PubMed ID: 6340242
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of Blood Glucose Reporting on Glycemic Variability in Veterans With Diabetes.
    Mangrum C; Smith L; Shivaswamy V
    J Diabetes Sci Technol; 2015 Aug; 9(6):1348-9. PubMed ID: 26285952
    [No Abstract]   [Full Text] [Related]  

  • 19. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery.
    Klonoff DC
    Pediatr Endocrinol Rev; 2003 Dec; 1(2):94-100. PubMed ID: 16437014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future directions for insulin therapy and diabetes treatment.
    Heinemann L
    Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2():69-79. PubMed ID: 18407034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.